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Overuse of colorectal cancer screening 




As a standard way for prevention and early detection of colorectal cancer (CRC), colonoscopy has been used for CRC 
screening in the United States for more than one decade. An article entitled “Assessing Colorectal Cancer Screening 
Adherence of Medicare Fee-For-Service Beneficiaries Age 76 to 95 Years” recently published at the Journal of Oncology 
Practice reports the trends in overuse of CRC screening services among average-risk elderly populations at the age 
of 76–95 years. Several reasons for overusing colonoscopy have been postulated, and some strategies for reducing 
overuse of CRC screening services have also been proposed.
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A few days ago, I ran into a middle-aged lady whom I 
used to see frequently jogging in our neighborhood. She 
appeared stressed out and very tired. I was concerned 
and inquired about how had been with her. She told me 
that she had been looking after her sick mother in the 
past 4 months. Her mother, in her mid-eighties, had been 
very healthy until she was hospitalized for pneumonia 
last December in 2015. During her hospitalization, her 
doctor seemingly randomly asked whether she ever had 
colorectal cancer (CRC) screening tests. After told no 
test being done in the past, her doctor ordered a screen-
ing colonoscopy while she was in the hospital. Unfor-
tunately, this procedure led to perforation and forced 
her into a prolonged hospital stay. Her mother was still 
recovering from this colonoscopy-related complication.
An article entitled “Assessing Colorectal Cancer Screen-
ing Adherence of Medicare Fee-For-Service Beneficiaries 
Age 76 to 95 Years” recently published at the Journal of 
Oncology Practice (JOP) by Bian et al. [1] highlighted the 
trends in the overuse of CRC screening services among 
average-risk elderly populations at the age of 76–95 years 
from 2002 to 2010. CRC screening is an effective and 
a cost-effective way for reducing CRC-related death. 
However, these screening services, particularly colonos-
copy, may carry some risks. Specifically, screening colo-
noscopies may expose patients to polypectomy-related 
perforation and bleeding risks and to sedation-related 
cardiovascular and pulmonary complications. The level 
of these risks may also be elevated with age. As a result, 
after weighing in the benefit-and-risk tradeoff, the United 
States (US) Preventive Services Task Force (USPSTF) 
does not recommend routine CRC screening to indi-
viduals over age 75 years at an average risk of CRC (e.g., 
without family history of CRC or prior polyp/adenoma 
history) [2]. In spite of the above explicit recommendation 
by the USPSTF, almost all major health insurance pro-
grams in the US, such as the Medicare program (a nation-
wide health insurance for the elderly age over 65  years), 
have continued their coverage for CRC screening of the 
average-risk individuals without setting upper-age limit. 
Consequently, there has been a growing concern about 
potential overuse of CRC screening services after Medi-
care started coverage of all four main CRC screening 
modalities (including colonoscopy) in 2001 [3].
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This JOP article [1] reports an observational study 
designed for addressing this concern. This study used a 
5% random non-cancer sample of Medicare fee-for-ser-
vice (FFS) enrollees during 2002–2010 residing in the 
Surveillance, Epidemiology, and End Results (SEER) areas 
to construct a 9-year study cohort that included average-
risk enrollees at the age of 76–95  years. The two out-
comes of interest were the up-to-date status (in a given 
year) of adherence to overall CRC screening and to colo-
noscopy (versus the other three modalities). The authors 
additionally analyzed a sample of average-risk enrollees 
at the age of 86–95 years, in which any screening services 
received may be deemed overuse of CRC screening ser-
vices according to the USPSTF recommendation.
The authors found that overall CRC screening 
adherence rates for studied individuals at the age of 
76–95  years rose from 13.0% in 2002 to 21.4% in 2010. 
In 2002, 2.2% were adherent to colonoscopy, and 10.7% 
to the other three modalities; in 2010, the corresponding 
rates were 19.5 and 1.9%. The rapid rise in overall adher-
ence rates may be a result of Medicare coverage policy 
of screening colonoscopy for average-risk beneficiaries 
starting in 2001, and a longer recommended screening 
interval of 10 years. Our additional analysis of the enroll-
ees at the age of 86–95 years demonstrated that the over-
all adherence rates were almost doubled from 6.7% in 
2002 to 12.5% in 2010. These increases, largely driven by 
colonoscopy use, may represent a significant portion of 
overuse of CRC screening services.
There are at least three plausible reasons for the 
observed potential overuse. First, the direct financial 
incentive in a Medicare FFS environment may promote 
over-prescription of these services. Second, because the 
CRC screening adherence rate has been widely used as a 
quality indicator for measuring performance of health-
care provider, perceived higher rates may suggest higher 
health care quality and in turn may indirectly lead to 
higher payment for better performance. Third, because 
many providers may be overwhelmed by day-to-day busy 
clinical practice, particularly in primary care settings, 
they have little time for consulting patients about the 
benefits and risks of various cancer preventive services 
such as CRC screening. In the end, the authors cautiously 
offered some corresponding remedies for reducing over-
use of CRC screening services: redesigning value-based 
payment systems, measuring age-weighted CRC screen-
ing performance, and reimbursing physicians for their 
time discussing the trade-off of benefits and risks of 
screening colonoscopy.
Finally, this JOP article [1] may offer some insights of 
using observational data for cancer health services/out-
comes research in China. The dataset used in this study 
was longitudinal non-cancer data, paralleled to the SEER 
data (the cancer registry data covering a quarter of the 
US populations). A large body of evidence has been pub-
lished from these datasets on cancer topics related to 
epidemiology, prevention, treatment, and survivorship. 
In addition, these datasets have been increasingly used 
for cancer health policy research [4, 5]. Undoubtedly, 
the evidence generated from these valuable datasets may 
have contributed to remarkable improvement in cancer 
survivorship in the US over the past four decades. As 
cancer death is becoming a major health burden in China 
[6, 7], more research that uses nationally representative 
cancer registry and other observational data is critically 
needed to monitor progresses of quality and outcomes of 
cancer care in China.
Received: 10 June 2016   Accepted: 11 June 2016
References
 1. Bian J, Bennett C, Cooper G, D’Alfonso A, Fisher D, Lipscomb J, Qian CN. 
Assessing colorectal cancer screening adherence of medicare fee-for-
service beneficiaries age 76 to 95 years. J Oncol Pract. 2016;12(6):e670–
80. doi:10.1200/JOP.2015.009118.
 2. US Preventive Services Task Force. Screening for colorectal cancer (USP-
STF): US preventive services task force recommendation statement. Ann 
Intern Med. 2008;149:627–37.
 3. Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screen-
ing colonoscopy in the medicare populations. Arch Intern Med. 
2011;171:1335–43.
 4. Bian J, Halpern MT. Trends in outpatient breast cancer surgery among 
Medicare fee-for-service patients in the United States from 1993 to 2002. 
Chin J Cancer. 2011;30:197–203.
 5. Bian J, Lipscomb J, Mello MM. Spillover effects of state mandated-
benefit laws: the case of outpatient breast cancer surgery. Inquiry. 
2009/2010;46:433–47.
 6. Zhou Q, Li K, Lin GZ, Shen JC, Dong H, Gu YT, et al. Incidence trends 
and age distribution of colorectal cancer by subsite in Guangzhou, 
2000–2011. Chin J Cancer. 2015;34(8):358–64.
 7. Chen WQ, Zheng RS, Zhang SW, Zeng HM, Zou XN. The incidences 
and mortalities of major cancers in China, 2010. Chin J Cancer. 
2014;33(8):402–5.
